proteosome-based vaccine V-2 (GlaxoSmithKline)
N/A
Report date: 2026/01/26 17:59:03
Base Information
Drug Nameproteosome-based vaccine V-2 (GlaxoSmithKline)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A